Quick Answer
Envoy Medical, Inc. reported Cash and Equivalents of $4.22 million for fiscal year 2023.
Envoy Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2023 | $4.22M | +2204.9% |
| 2022 | $183.0K | +22.1% |
| 2021 | $149.8K | +499.4% |
| 2020 | $25.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $7.44M | +2363.6% | +5503.5% |
| June 30, 2023 | $132.8K | -72.2% | +27.6% |
| March 31, 2023 | $104.0K | -18.2% | -43.2% |
| December 31, 2022 | $183.0K | +22.1% | -39.4% |
| September 30, 2022 | $302.0K | -70.7% | -36.7% |
| June 30, 2022 | $476.9K | -72.6% | +275.2% |
| March 31, 2022 | $127.1K | -94.1% | -15.2% |
| December 31, 2021 | $149.8K | +499.4% | -85.5% |
- Envoy Medical, Inc. showed an increase of +2204.9% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2023 period, Envoy Medical, Inc.’s cash and equivalents has grown by 16772.0% (from $25.0 thousand to $4.22 million).
- The most recent figure is from Envoy Medical, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 1, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: